A groundbreaking shift in Canadian drug policy has taken place, as the authorities permit the use of psilocybin hallucinogens for therapeutic purposes. Before this, these substances were severely restricted, but a increasing body of research suggests they could offer relief for mental health illnesses like anxiety. The new policy represents a key s